CJC-1295 research guide for Schrems. Covers DAC vs no-DAC forms, half-life differences, purity testing, and how to source quality CJC-1295 for research.
For anyone in Schrems searching for CJC-1295, the key fact to understand is that this compound is available only through an online research supply market. The core insight for Schrems researchers: sourcing CJC-1295 hinges on vendor quality evaluation, not geography — and the quality verification approach is the same regardless of where you are. A legitimate CJC-1295 supplier's COA should include HPLC purity, mass spectrometry confirmation of molecular identity, bacterial endotoxin testing, and a residual solvents panel — all traceable to your specific batch. The sections below cover what Schrems researchers need to know about finding, evaluating, and storing CJC-1295 for research purposes.
How CJC-1295 Works — Mechanisms & Research
CJC-1295 with DAC (Drug Affinity Complex) is a GHRH analogue with an extended half-life achieved through DAC technology that enables covalent binding to albumin. This modification extends the half-life from minutes (for native GHRH) to approximately 6-8 days, creating a sustained elevation in basal GH levels rather than the pulsatile pattern produced by GHRP compounds. This pharmacokinetic distinction is significant for research design: CJC-1295 based on CJC-1295 with DAC produces a different GH secretion pattern than GHRP compounds, with different downstream effects on IGF-1 and protein synthesis. Researchers in Schrems comparing compounds in this class should account for these pharmacokinetic differences in their experimental design.
CJC-1295 Purchasing Guide
Assessing CJC-1295 vendors starts with the COA: request the batch-specific certificate before purchasing, not after. Endotoxin testing in the COA is critical for any injectable research use — endotoxins from bacterial cell wall components can trigger dangerous inflammatory cascades even at minute levels. Signs of a credible vendor beyond COA quality: established track record of at least two years, responsive technical support who understand testing methodology, and temperature-appropriate packaging with desiccant. The powdered lyophilised form of CJC-1295 is far superior to liquid pre-made solutions — lyophilised powder retains potency for years in frozen storage, while liquid preparations degrade within weeks even when refrigerated.
Order CJC-1295 — ships to Schrems
COA-verified · International tracking · Research grade
All use of CJC-1295 in Schrems or anywhere must be research use only — this compound is not approved for therapeutic human application, and all handling should follow research laboratory protocols. Proper handling of CJC-1295 requires strict sterile technique during reconstitution — swabbed septum with alcohol prep pad, new needle for each draw, clean preparation area — and cold chain maintenance from receipt through use. Verify the endotoxin level in your CJC-1295 batch COA before any injectable research application — look for results expressed as EU/mg or EU/mL and compare against acceptable research limits for your application. For any individual considering CJC-1295 outside a formal research context: speak with a healthcare professional — this compound is not a licensed human medication and its risk profile is not equivalent to approved medications.
Frequently Asked Questions
What is CJC-1295?
CJC-1295 is a synthetic GHRH (Growth Hormone Releasing Hormone) analogue. The version with DAC (Drug Affinity Complex) has an extended half-life of approximately 6-8 days due to albumin binding. Without DAC, CJC-1295 has a much shorter half-life similar to native GHRH. Both versions stimulate pulsatile GH release via the GHRH receptor.
What is the difference between CJC-1295 with DAC and without DAC?
CJC-1295 with DAC uses a lysine-maleimide conjugate to bind covalently to albumin in the bloodstream, extending half-life to ~6-8 days and creating sustained GH elevation. CJC-1295 without DAC (also called Mod GRF 1-29) has a half-life of ~30 minutes and produces acute GH pulses. They produce different GH secretion patterns and have different applications in research.
What purity is required for CJC-1295 research?
CJC-1295 should be ≥98% pure by HPLC. The larger molecular weight of CJC-1295 with DAC (approximately 3647 Da) makes mass spectrometry confirmation particularly important, as impurities may not be obvious on HPLC alone.
